FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

527 letters match. Newest first.

  1. JZ Wholesale, Inc.

    FDA warned JZ Wholesale after finding widespread rodent and insect contamination in food at its Fort Smith, Arkansas warehouse.

    High risk
  2. Trangs Group USA Incorporated

    FDA inspection found Trangs Group USA, an importer, lacked a foreign supplier verification program for Frozen Bao Mini Mushroom Teriyaki Bun.

    Medium
  3. Fareva Morton Grove

    FDA found microbial contamination risks and data integrity failures at Fareva Morton Grove's OTC drug manufacturing.

    High risk
  4. NSE Products, Inc. DBA Nu Skin Enterprises, Inc.

    FDA warns NSE Products (Nu Skin) over incomplete drug listing data for AP-24 products and 61 inactivated listings.

    Low
  5. Rio Verde Food Service Inc.

    FDA warns Rio Verde Food Service that its live oyster safety plan lacks temperature controls needed to prevent pathogens.

    High risk
  6. El Rey USA Meats & Seafood Inc.

    FDA found El Rey USA Meats & Seafood lacked required importer verification for shrimp and tilapia.

    High risk
  7. GenoGenix LLC

    FDA warns GenoGenix over insanitary sterile compounding, endotoxin-contaminated NAD+, and unapproved drugs.

    High risk
  8. R.R. Importaciones Inc.

    FDA found R.R. Importaciones Inc. lacked required foreign food supplier verification, including for chocolate.

    Medium
  9. The Father's Table, LLC

    FDA warned The Father's Table that its ready-to-eat cheesecakes and cake rolls were adulterated after Listeria monocytogenes was found in the facility.

    High risk
  10. John Yoder Farm

    FDA warns John Yoder Farm over shell eggs and missing Salmonella prevention plan.

    High risk
  11. Supercan Bully Sticks LLC

    Supercan Bully Sticks lacked a foreign supplier verification program and written food safety plan after Salmonella recall of pig ear treats.

    High risk
  12. Las Americas Supermercado#2 Inc.

    FDA warns Las Americas Supermercado#2 over missing FSVP for imported cabbage, green prickly pear, and fresh cilantro.

    Medium
  13. Dynamic Stem Cell Therapy

    FDA warned Dynamic Stem Cell Therapy that its umbilical cord-derived stem cell product is an unapproved, unlicensed, misbranded biological drug.

    High risk
  14. ExThera Medical Corporation

    ExThera shipped Seraph 100 blood filters for compassionate use without FDA approval and promoted them as approved.

    High risk
  15. East CK Trading Inc.

    East CK Trading lacked an FSVP for imported ginseng, wolfberry, and mushroom seasoning, FDA says.

    Medium
  16. Fidelity Melon, Inc

    FDA warns Fidelity Melon for lacking foreign supplier verification for imported melons.

    Medium
  17. ProDx Health

    FDA warns ProDx Health that its HIV sample self-collection kits are sold without marketing authorization.

    High risk
  18. Central Coast Multispecialty Medical Group, Inc.

    FDA warns Central Coast Multispecialty Medical Group over incomplete donor screening and eligibility for reproductive tissue.

    High risk
  19. Conceive Fertility Center

    FDA says Conceive Fertility Center in Dallas used incomplete donor screening and testing for reproductive cells.

    High risk
  20. Louisville Reproductive Center

    Louisville Reproductive Center failed to properly test and screen semen donors for infectious diseases, FDA found.

    High risk
  21. Flextronics America LLC

    FDA warns Flextronics America, contract maker of FreeStyle Libre 3 glucose sensors in Austin, TX, over an unvalidated assembly step and weak corrective actions.

    High risk
  22. Unomedical Device S.A. de C.V.

    FDA warns Unomedical over insulin infusion sets with unvalidated leak tests and unreported serious injuries.

    High risk
  23. Eniva USA, Inc.

    FDA warns Eniva USA over manufacturing quality failures for Immune Support and Ashwagandha Gummies.

    Medium
  24. Zip Foods Importers, Inc

    Zip Foods Importers lacked required foreign supplier verification programs for many imported foods, FDA found.

    Medium
  25. Meridian Bioscience, Inc

    FDA warns Meridian Bioscience's Magellan Diagnostics over quality system failures and unreported problems with its blood lead test kits.

    High risk
  26. MAST Biosurgery USA, Inc.

    MAST Biosurgery USA never ran promised endotoxin tests on its SurgiWrap FROST surgical mesh and failed to report patient injuries, FDA says.

    High risk
  27. Asli Foods, Inc

    Asli Foods, a food importer, lacked required foreign supplier checks for chocolate, tea, and kabab mix, FDA says.

    Medium
  28. MG GROUP USA

    MG GROUP USA lacked FSVP records for imported truffle oil and fresh truffles, FDA found during an August 2025 inspection.

    Medium
  29. American Food Distributor Inc.

    FDA warns American Food Distributor for missing FSVP for imported tahina, olive oil, and mallow leaves.

    Medium
  30. Germaphobix

    FDA warns Germaphobix that its unapproved HIV dried blood spot self-collection kit is adulterated and misbranded.

    High risk
  31. LXR Biotech, LLC

    FDA warns LXR Biotech over CGMP (manufacturing quality rules) failures for Eternal Energy supplements, making them adulterated (legally unfit as made).

    Medium
  32. Chemspec Chemicals Private Limited

    FDA warns Indian API maker Chemspec Chemicals over missing batch records and data integrity failures.

    High risk
  33. ASP Global, LLC. dba Anatomy Supply Partners, LLC.

    FDA cites ASP Global for quality-system, reporting, and unapproved-change violations involving Safe-T-Fill blood collection devices.

    High risk
  34. Palamur Biosciences Private Limited

    FDA warns Palamur Biosciences over GLP violations in medical device safety testing and inadequate corrective actions.

    High risk
  35. Revive Rx LLC dba Revive Rx Pharmacy

    FDA warns Revive Rx Pharmacy over insanitary production of sterile compounded drugs, citing contamination risks.

    High risk
  36. TG Supply LLC d/b/a TransGuy Supply

    FDA warned TransGuy Supply that its breast binders are unregistered, unlisted medical devices.

    Low
  37. Flux Lab Pte. Ltd. d/b/a The Fluxion

    FDA warns Flux Lab/The Fluxion over unregistered, unlisted chest binders marketed as medical devices.

    Medium
  38. FLAVNT Streetwear, LLC

    FDA says FLAVNT Streetwear sold breast binders as medical devices without registering or listing them for fiscal 2026.

    Low
  39. Early to Bed, Inc.

    FDA warned Early to Bed, Inc. that its breast binders are misbranded because the manufacturer was not registered or listed with FDA.

    Low
  40. GenderBender LLC

    GenderBender LLC sells breast binders as medical devices without FDA registration or listing, making them misbranded.

    Low
  41. TomboyX, PBC

    FDA says TomboyX sells breast binders as medical devices without registering or listing them, making them misbranded.

    Medium
  42. Philadelphia 7, Inc d/b/a Passional Boutique

    FDA says Philadelphia 7 sold unregistered, unlisted breast binders, making them misbranded devices.

    Low
  43. For Them, Inc.

    FDA says For Them, Inc. sells breast binders as unregistered medical devices, making them misbranded.

    Low
  44. ShapeShifter Apparel, LLC

    FDA says ShapeShifter Apparel sold breast binders as unregistered, unlisted medical devices, making them misbranded.

    Low
  45. Green Valley Fertility Partners

    FDA cited Green Valley Fertility Partners for donor eligibility failures involving oocyte HCT/Ps, including missing communicable disease testing and screening.

    High risk
  46. Microvascular Tissue, Inc.

    FDA says Microvascular Tissue's mVASC wound product is an unapproved drug and unlicensed biologic, made without validated processes.

    High risk
  47. Celularity, Inc

    FDA warns Celularity that Interfyl is an unapproved new drug and unlicensed biological product marketed for orthopedic and wound uses.

    High risk
  48. Lux Therapeutics LLC dba Ponya Therapeutics LLC

    FDA warns Lux Therapeutics over unvalidated TheraMend amniotic patches and records, citing inadequate response and Luxegen distribution concerns.

    High risk
  49. Delucas Bakery Corp

    FDA warns Delucas Bakery Corp over unsanitary conditions, missing food safety plan, and undeclared allergens in ready-to-eat rolls and buns.

    High risk
  50. PQ Pharmacy, LLC

    FDA warns PQ Pharmacy, a Florida sterile drug compounder, that its products were made under unsafe conditions.

    High risk